A Study to Evaluate the Effectiveness and Safety of ExAblate MRgFUS on Essential Tremor
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
Sponsor: InSightec
Terminated
Sponsor decision
Other terminated trials from InSightec
Other Essential Tremor trials with similar outcome
Listed as NCT03253991, this NA trial focuses on Essential Tremor and remains terminated or withdrawn. Sponsored by InSightec, it has been updated 12 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2023 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Oct 2021 — May 2023 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Recruiting NA
-
Dec 2018 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
-
Sep 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- InSightec
For direct contact, visit the study record on ClinicalTrials.gov .